Upload
others
View
6
Download
0
Embed Size (px)
Citation preview
Supporting information
Design, synthesis, insecticidal activity and 3D‐QSR study for novel
trifluoromethyl pyridine derivatives containing an 1,3,4‐oxadiazole
moiety
F.Z. Xua, Y.Y. Wanga, †, D.X. Luoa, G. Yua, S.X. Guoa, H. Fua, Y.H. Zhaob, and J. Wua‡
a. State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key
Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education,
Research and Development Center for Fine Chemicals, Guizhou University, Huaxi District,
Guiyang, P.R. China, 550025.
b. Institute for the Control of Agrochemicals, Ministry of Agriculture, Beijing, China. 100125.
Corresponding author; E-mail address: [email protected], [email protected]
‡ Co-first author for this manuscript.
†To whom correspondence should be addressed. Tel.: +86(851)88292090; fax: +86(851)
88292090. E-mails: [email protected], [email protected]
1. Superimposition of compounds for the 3D-QSAR study
Fig. S1 Superimposition of compounds for the 3D‐QSAR study. (A). Common substructure; (B) result of
superimposition
Electronic Supplementary Material (ESI) for RSC Advances.This journal is © The Royal Society of Chemistry 2018
2. The Tables for the results of 3D-QSAR study
Table S1. Statistical parameters of CoMFA and CoMSIA models
Statistical parameter CoMFA CoMSIA
q2 a 0.742 0.614
ONC b 5 6
r2 c 0.975 0.92
Standard Error of Estimate 0.044 0.084
F values 92.362 32.793
Fraction of field contributions d
Steric 0.586 0.511
Electrostatic 0.414 0.489
Hydrophobic ‐ 0
Hydrogen‐bond Donor ‐ 0
Hydrogen‐bond Acceptor ‐ 0
a Cross‐validated correlation; b Optimum number of components;
c Non‐cross‐validated correlation; f Field contributions.
Table S2. Results of experimental pLC50 and predicted pLC50
Compounds Experimental PLC50 CoMFA CoMSIA
Predc.a Res.b Predc.a Resb
E1 3.058 3.014 0.046 3.054 0.004
E2 3.16 3.173 ‐0.033 3.153 0.007
E3 3.632 3.664 0.003 3.654 ‐0.022
E4 3.240 3.279 ‐0.033 3.224 0.016
E5 3.896 3.843 0.047 3.923 ‐0.027
E6 3.573 3.565 0.011 3.586 ‐0.013
E7* 3.615 3.493 0.122 3.809 ‐0.194
E8* 3.731 3.729 0.022 3.79 ‐0.059
E9* 3.82 3.847 0.047 3.861 ‐0.041
E10 3.603 3.635 ‐0.125 3.737 ‐0.134
E11 3.808 3.921 ‐0.114 3.745 0.063
E12 3.836 3.803 0.092 3.811 0.025
E13 3.975 4.003 ‐0.028 4.043 ‐0.068
E14 3.788 3.684 0.113 3.748 0.04
E15 3.863 3.901 0.099 3.787 0.076
E16* 3.768 3.797 ‐0.029 3.79 ‐0.022
E17 3.765 3.725 ‐0.16 3.748 0.017
E18 4.009 4.011 ‐0.002 4.010 ‐0.001
E19 3.824 3.854 0.028 3.856 ‐0.032
E20 3.683 3.691 0.027 3.654 0.029
E21 3.835 3.824 0.031 3.79 0.045
E22* 3.634 3.683 ‐0.019 3.765 ‐0.131
E23 3.742 3.772 0.03 3.744 ‐0.002
E24 3.659 3.679 ‐0.07 3.755 ‐0.096
E25 3.646 3.674 ‐0.178 3.765 ‐0.119
E26* 3.806 3.904 0.002 3.805 0.001
E27# 4.106 4.055 0.051 3.855 0.251
E28# 3.442 3.406 ‐0.184 3.47 ‐0.028
*Sample of the test set; # Componds Predicted by the 3D‐QSAR models
3. The 1H, 13C, 19F NMR and HR-MS spectra of the title compounds
Fig. S2 1H NMR spectra of compound E1
Fig. S3 13C NMR spectra of compound E1
Fig. S4 19F NMR spectra of compound E1
Fig. S5 HR-MS spectra of compound E1
2017120106 #105 RT: 1.02 AV: 1 NL: 8.64E7T: FTMS + p ESI Full ms [100.0000-1000.0000]
280 290 300 310 320 330 340 350 360 370
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
326.02969C14 H8 O N3 Cl F3 = 326.03025
-1.70885 ppm
340.25894
328.02670348.01163
351.24997362.24075
284.29431 338.34109360.32315309.27826301.14056 323.25775 367.21878331.25314291.19412
Fig. S8 19F NMR spectra of compound E2
Fig. S9 HR-MS spectra of compound E2
2017121507 #151 RT: 1.47 AV: 1 NL: 1.47E7T: FTMS + p ESI Full ms [100.0000-1000.0000]
370.0 370.5 371.0 371.5 372.0 372.5 373.0 373.5 374.0 374.5 375.0 375.5
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
374.00598C15 H9 O N3 Cl2 F3 = 374.00693
-2.53211 ppm
375.00980370.22757
371.22653
373.12787C15 H8 O N3 Cl2 F3 = 372.99910
345.09674 ppm
Fig. S12 19F NMR spectra of compound E3
Fig. S13 HR-MS spectra of compound E3
2017121508 #147 RT: 1.43 AV: 1 NL: 2.35E7T: FTMS + p ESI Full ms [100.0000-1000.0000]
370.0 370.5 371.0 371.5 372.0 372.5 373.0 373.5 374.0 374.5 375.0 375.5
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
374.00607C15 H9 O N3 Cl2 F3 = 374.00693
-2.28732 ppm
375.00967
370.22778 371.22678 373.12759372.38257 374.13120
Fig. S16 19F NMR spectra of compound E4
Fig. S17 HR-MS spectra of compound E4
2017120152 #123 RT: 1.19 AV: 1 NL: 7.22E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
339.0 339.5 340.0 340.5 341.0 341.5
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
340.04596C15 H10 O N3 Cl F3 = 340.04590
0.17254 ppm
341.04938340.25949
340.76126339.34500
Fig. S20 19FNMR spectra of compound E5
Fig. S21 HR-MS spectra of compound E5
2017120153 #175 RT: 1.69 AV: 1 NL: 5.44E5T: FTMS + p ESI Full ms [100.0000-1000.0000]
390.0 390.5 391.0 391.5 392.0 392.5 393.0 393.5 394.0 394.5 395.0 395.5
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
393.95306C14 H6 O N3 Cl3 F3 = 393.95231
1.92379 ppm
393.21002
394.87494
395.21527
Fig. S24 19F NMR spectra of compound E6
Fig. S25 HR-MS spectra of compound E6
2017120154 #135 RT: 1.31 AV: 1 NL: 2.38E7T: FTMS + p ESI Full ms [100.0000-1000.0000]
352.5 353.0 353.5 354.0 354.5 355.0 355.5 356.0
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
354.06137C16 H12 O N3 Cl F3 = 354.06155
-0.50842 ppm
355.06497
353.26611
354.13242
352.75519353.98389
Fig. S28 19F NMR spectra of compound E7
Fig. S29 HR-MS spectra of compound E7
2017120155 #147 RT: 1.43 AV: 1 NL: 6.97E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
352 353 354 355 356 357 358
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
354.06128C16 H12 O N3 Cl F3 = 354.06155
-0.76699 ppm
356.05838
355.06509352.25476357.06146353.26584352.75476 355.25140 358.26953354.23856
Fig. S32 19F NMR spectra of compound E8
Fig. S33 HR-MS spectra of compound E8
2017120155 #147 RT: 1.43 AV: 1 NL: 6.97E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
352 353 354 355 356 357 358
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
354.06128C16 H12 O N3 Cl F3 = 354.06155
-0.76699 ppm
356.05838
355.06509352.25476357.06146353.26584352.75476 355.25140 358.26953354.23856
Fig. S36 19F NMR spectra of compound E9
Fig. S37 HR-MS spectra of compound E9
2017120156 #135 RT: 1.31 AV: 1 NL: 3.06E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
433 434 435 436 437 438 439
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
437.90149C14 H6 O N3 Br Cl2 F3 = 437.90179
-0.68902 ppm
437.23550
438.90472434.75717
433.28372 438.23853435.25897 435.75812 436.64069434.30240 439.24121433.74002
Fig. S40 19FNMR spectra of compound E10
Fig. S41 HR-MS spectra of compound E10
2017120157 #137 RT: 1.33 AV: 1 NL: 5.98E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
447.0 447.5 448.0 448.5 449.0 449.5 450.0 450.5 451.0 451.5 452.0 452.5 453.0
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
451.92648C14 H7 O N3 Cl F3 I = 451.92689
-0.90846 ppm
452.93011
449.76764447.76233 450.27020 452.77679448.26459 448.76245 450.76971
Fig. S44 19F NMR spectra of compound E11
Fig. S45 HR-MS spectra of compound E11
2017120158 #127 RT: 1.23 AV: 1 NL: 8.53E5T: FTMS + p ESI Full ms [100.0000-1000.0000]
400.0 400.5 401.0 401.5 402.0 402.5 403.0 403.5 404.0 404.5 405.0
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
403.94077C14 H7 O N3 Br Cl F3 = 403.94076
0.00513 ppm
401.26208 404.94385403.73834402.37558
Fig. S48 19F NMR spectra of compound E12
Fig. S49 HR-MS spectra of compound E12
2017120159 #119 RT: 1.16 AV: 1 NL: 4.62E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
419.5 420.0 420.5 421.0 421.5 422.0 422.5 423.0 423.5
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
421.93088C14 H6 O N3 Br Cl F4 = 421.93134
-1.09922 ppm
419.78622
423.76077
422.93506
421.65155420.28882422.76361421.25790420.78885 423.27451422.29257
Fig. S52 19F NMR spectra of compound E13
Fig. S53 HR-MS spectra of compound E13
2017120160 #95 RT: 0.92 AV: 1 NL: 2.31E7T: FTMS + p ESI Full ms [100.0000-1000.0000]
341 342 343 344 345 346 347 348
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
344.02042C14 H7 O N3 Cl F4 = 344.02083
-1.19949 ppm
346.01746
345.02405341.26254
347.02118344.22760343.20084341.76422 342.24527 348.02390345.23029
Fig. S56 19F NMR spectra of compound E14
Fig. S57 HR-MS spectra of compound E14
2017120161 #131 RT: 1.27 AV: 1 NL: 6.25E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
400.0 400.5 401.0 401.5 402.0 402.5 403.0 403.5 404.0 404.5 405.0 405.5
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
403.94049C14 H7 O N3 Br Cl F3 = 403.94076
-0.67482 ppm
405.80637404.94418401.26169 405.31323404.73062400.27866 403.20920402.23306
403.73874
Fig. S60 19F NMR spectra of compound E15
Fig. S61 HR-MS spectra of compound E15
2017120162 #151 RT: 1.47 AV: 1 NL: 1.35E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
390 391 392 393 394 395
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
393.95209C14 H6 O N3 Cl3 F3 = 393.95231
-0.55509 ppm
393.20895
391.28357
392.74756394.95560
394.21234390.73264 393.72900391.61905 392.28668 395.79291
Fig. S64 HR-MS spectra of compound E16
Fig. S65 1H NMR spectra of compound E17
2017122661 #123 RT: 1.19 AV: 1 NL: 5.19E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
359.5 360.0 360.5 361.0 361.5
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
359.99057C14 H7 O N3 Cl2 F3 = 359.99128
-1.96767 ppm
360.32306359.73376
360.99466360.23566361.32666
359.31482 360.73737 361.23056
Fig. S68 HR-MS spectra of compound E17
2017120164 #123 RT: 1.19 AV: 1 NL: 6.66E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
357.0 357.5 358.0 358.5 359.0 359.5 360.0 360.5 361.0 361.5
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
359.99078C14 H7 O N3 Cl2 F3 = 359.99128
-1.37425 ppm
359.23248360.32321
359.73380
361.32675360.99472
357.28574 358.27008 360.75638
Fig. S71 19F NMR spectra of compound E18
Fig. S72 HR-MS spectra of compound E18
2017120165 #95 RT: 0.92 AV: 1 NL: 4.53E7T: FTMS + p ESI Full ms [100.0000-1000.0000]
390.0 390.5 391.0 391.5 392.0 392.5 393.0 393.5 394.0 394.5 395.0 395.5 396.0
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
394.01730C15 H7 O N3 Cl F6 = 394.01764
-0.84220 ppm
395.02087
393.20947391.28418
393.72781
394.22897 395.22607395.79385
392.74802390.73282
Fig. S75 19F NMR spectra of compound E19
Fig. S76 HR-MS spectra of compound E19
2017120166 #111 RT: 1.08 AV: 1 NL: 9.19E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
390 391 392 393 394 395 396
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
394.01740C15 H7 O N3 Cl F6 = 394.01764
-0.60985 ppm
396.01434
395.02112393.20935391.28394 392.74765 396.23462391.72211 395.22525394.21271390.73242
395.79288
393.72937
Fig. S83 HR-MS spectra of compound E21
2017121509 #127 RT: 1.24 AV: 1 NL: 8.70E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
375.0 375.5 376.0 376.5 377.0 377.5 378.0 378.5 379.0 379.5
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
377.98135C14 H6 O N3 Cl2 F4 = 377.98186
-1.33028 ppm
378.98532
378.21548376.29721 377.30109 379.21014378.62299 379.70999
Fig. S86 19F NMR spectra of compound E22
Fig. S87 HR-MS spectra of compound E22
2017121510 #103 RT: 1.00 AV: 1 NL: 5.58E7T: FTMS + p ESI Full ms [100.0000-1000.0000]
341.5 342.0 342.5 343.0 343.5 344.0 344.5 345.0 345.5
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
344.02029C14 H7 O N3 Cl F4 = 344.02083
-1.55433 ppm
345.02386
341.76349 343.28403342.26517 344.22696343.84476342.74615 345.23029
Fig. S90 19F NMR spectra of compound E23
Fig. S91 HR-MS spectra of compound E23
2017121503 #111 RT: 1.08 AV: 1 NL: 1.26E8T: FTMS + p ESI Full ms [100.0000-1000.0000]
391.0 391.5 392.0 392.5 393.0 393.5 394.0 394.5 395.0 395.5 396.0
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
394.01685C15 H7 O N3 Cl F6 = 394.01764
-2.00399 ppm
395.02032
391.28375 393.29721 394.40359393.80685
392.28720 395.40717391.72137 392.72086
Fig. S94 19F NMR spectra of compound E24
Fig. S95 HR-MS spectra of compound E24
2017120171 #133 RT: 1.29 AV: 1 NL: 4.62E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
448.0 448.5 449.0 449.5 450.0 450.5 451.0 451.5 452.0 452.5 453.0
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
451.92661C14 H7 O N3 Cl F3 I = 451.92689
-0.63835 ppm
452.92993449.76852 450.27072448.26550 452.77762450.77103449.26346 451.74231
452.25742
Fig. S98 19F NMR spectra of compound E25
Fig. S99 HR-MS spectra of compound E25
2017121511 #133 RT: 1.30 AV: 1 NL: 7.38E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
448.0 448.5 449.0 449.5 450.0 450.5 451.0 451.5 452.0 452.5 453.0
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
451.92636C14 H7 O N3 Cl F3 I = 451.92689
-1.17857 ppm
451.09946
452.93008452.10272
451.30325448.26477 452.77621449.26376 453.24210448.76263 450.27094
Fig. S102 19F NMR spectra of compound E26
Fig. S103 HR-MS spectra of compound E26
2017120173 #119 RT: 1.16 AV: 1 NL: 1.08E7T: FTMS + p ESI Full ms [100.0000-1000.0000]
367.0 367.5 368.0 368.5 369.0 369.5 370.0
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
369.07220C16 H13 O N4 Cl F3 = 369.07245
-0.66464 ppm
367.21884 370.07599
367.72055 368.21994367.05692 368.72073 369.23978
Fig. S106 19F NMR spectra of compound E27
Fig. S107 HR-MS spectra of compound E27
2017122606 #87 RT: 0.87 AV: 1 NL: 9.17E6T: FTMS + p ESI Full ms [100.0000-1000.0000]
355.0 355.5 356.0 356.5 357.0 357.5 358.0 358.5 359.0 359.5 360.0
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
358.03613C15 H9 O N3 Cl F4 = 358.03648
-0.96682 ppm
359.03976
359.23578355.28418 358.36807 359.73471
Fig. S110 19FNMR spectra of compound E28
Fig. S111 HR-MS spectra of compound E28
2017120163 #139 RT: 1.35 AV: 1 NL: 1.46E7T: FTMS + p ESI Full ms [100.0000-1000.0000]
390.0 390.5 391.0 391.5 392.0 392.5 393.0 393.5 394.0 394.5 395.0 395.5
m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
393.95184C14 H6 O N3 Cl3 F3 = 393.95231
-1.17481 ppm
394.95569
393.20932391.28339 395.79315394.21289392.74799391.72159
393.72812
390.73239 395.11008
394.75348